High-titre convalescent plasma therapy given within a week of symptom onset reduced hospitalisation and death and was well tolerated in immunocompromised patients with mild COVID-19. This randomised ...
Larazotide, an oral drug, may effectively treat MIS-C by tightening the gut epithelial barrier, reducing systemic inflammation. The phase 2a trial showed faster resolution of GI symptoms and spike ...
NEWTOWN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target ...
Nov 23 (Reuters) - Merck & Co Inc (MRK.N), opens new tab has agreed to acquire drugmaker OncoImmune in a deal that will give it control of a drug that could help ease symptoms and reduce deaths in ...
Even as the acute phase of the COVID-19 pandemic fades, the world continues to wrestle with its aftermath — and nowhere is that more evident than in the enduring challenge of Long COVID. The condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback